Aldose Reductase Inhibitors and Late Complications of Diabetes
- 1 January 1986
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 32 (2) , 43-55
- https://doi.org/10.2165/00003495-198600322-00010
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- The effects of a new aldose reductase inhibitor (tolrestat) in galactosemic and diabetic ratsMetabolism, 1985
- Aldose Reductase Inhibition, Glomerular Metabolism, and Diabetic NephropathyDiabetic Medicine, 1985
- Screening for treatable diabetic retinopathy.BMJ, 1985
- Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated ratsDiabetologia, 1985
- Glomerular Polyol Accumulation in Diabetes and its Prevention by Oral SorbinilDiabetes, 1984
- A Controlled Trial of Sorbinil, an Aldose Reductase Inhibitor, in Chronic Painful Diabetic NeuropathyDiabetes, 1983
- The effects of an aldose reductase inhibitor upon the sorbitol pathway, fructose-1-phosphate and lactate in the retina and nerve of streptozotocin-diabetic ratsExperimental Eye Research, 1983
- Inhibition of galactose-induced alterations in ocular lens with sorbinilExperimental Eye Research, 1983
- Assessment of Cardiovascular Effects in Diabetic Autonomic Neuropathy and Prognostic ImplicationsAnnals of Internal Medicine, 1980
- Aldose reductase inhibition: Studies with alrestatinMetabolism, 1979